Benefits
Supports joint comfort and mobility
Daily intake helps maintain comfortable joint movement and may reduce sensations of stiffness and discomfort during normal daily activity, supporting an active lifestyle as the joints age.
Promotes cartilage matrix support
The combination of Type II collagen peptides, chondroitin sulfate, and hyaluronic acid supplies the building blocks the body uses to maintain cartilage and synovial-fluid quality.
Aids recovery from exercise-induced stress
Helps maintain connective-tissue resilience and supports faster return to baseline performance markers following demanding resistance training or repetitive load.
Supports skin hydration and appearance
By contributing hydrolyzed collagen peptides and hyaluronic acid, BioCell helps maintain dermal hydration and the appearance of smoothness in skin already within the normal range.
Convenient single-source matrix
Delivers three complementary joint actives in one ingredient at a low daily dose, simplifying formulations compared with stacking standalone glucosamine, chondroitin, and HA.
Mechanism of action
Bioavailable collagen peptide delivery
Low-molecular-weight hydrolyzed Type II collagen peptides are absorbed intact as di- and tri-peptides that may serve as both substrates and signaling cues for chondrocyte matrix synthesis.
Chondroitin sulfate substrate
Supplies sulfated glycosaminoglycan precursors that contribute to proteoglycan assembly in cartilage and help maintain the osmotic resilience of the matrix.
Hyaluronic acid for synovial support
Oral HA fragments may stimulate endogenous hyaluronan synthesis in synoviocytes, supporting synovial-fluid viscoelasticity that lubricates and cushions joints.
Modulation of inflammatory mediators
Type II collagen peptides may engage gut-associated lymphoid tissue to help balance pro-inflammatory cytokine signaling, supporting a healthy inflammatory tone in joint tissues.
Clinical trials
Randomized, double-blind, placebo-controlled trial, 2 g/day for 70 days
n=80 adults with physician-verified progressive hip or knee OA
Participants taking BioCell experienced statistically significant reductions in pain scores compared with placebo, with improvements in physical function and stiffness measures supporting a benefit for joint comfort in adults with OA-related symptoms.
Randomized, double-blind, placebo-controlled pilot, 3 g/day for 6 weeks before a resistance-exercise challenge
n=8 healthy recreationally active adults (mean age ~29)
BioCell supplementation was associated with favorable changes in markers of muscle damage and recovery (including C-reactive protein and creatine kinase) and functional indices following an upper-body resistance protocol, supporting a role in connective-tissue protection during heavy training.